|
TNRC6C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.442700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.050000E-01 |
| Normal-vs-Stage2 |
7.219600E-02 |
| Normal-vs-Stage3 |
8.173100E-04 |
| Normal-vs-Stage4 |
7.53130000030744E-07 |
| Stage1-vs-Stage2 |
4.278000E-01 |
| Stage1-vs-Stage3 |
2.848200E-02 |
| Stage1-vs-Stage4 |
3.67949999999784E-05 |
| Stage2-vs-Stage3 |
6.911000E-01 |
| Stage2-vs-Stage4 |
1.254810E-01 |
| Stage3-vs-Stage4 |
5.873700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.075900E-03 |
| Normal-vs-AfricanAmerican |
5.747900E-02 |
| Normal-vs-Asian |
3.312800E-01 |
| Caucasian-vs-AfricanAmerican |
9.694400E-01 |
| Caucasian-vs-Asian |
4.454400E-02 |
| AfricanAmerican-vs-Asian |
1.150250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.063400E-03 |
| Normal-vs-Female |
2.436400E-02 |
| Male-vs-Female |
2.998400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.981700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.971900E-02 |
| Normal-vs-Age(61-80Yrs) |
6.400800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.355800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.476800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.940200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.902590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.642400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.715660E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.079900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.668000E-02 |
| Normal-vs-Grade 2 |
1.742410E-01 |
| Normal-vs-Grade 3 |
1.95378999999773E-05 |
| Normal-vs-Grade 4 |
2.30399999999742E-05 |
| Grade 1-vs-Grade 2 |
1.789660E-02 |
| Grade 1-vs-Grade 3 |
4.56729999998018E-06 |
| Grade 1-vs-Grade 4 |
1.23579999999901E-06 |
| Grade 2-vs-Grade 3 |
3.599900E-04 |
| Grade 2-vs-Grade 4 |
3.211200E-04 |
| Grade 3-vs-Grade 4 |
4.302600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.438780E-01 |
| Normal-vs-ccB subtype |
1.641630E-03 |
| ccA subtype-vs-ccB subtype |
1.426410E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.920600E-03 |
| Normal-vs-N1 |
1.323760E-03 |
| N0-vs-N1 |
9.607600E-02 |
|
|
